Debt-to-equity of Elevation Oncology, Inc. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Elevation Oncology, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 31 Mar 2025.
Elevation Oncology, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was 55%, a 2.1% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Elevation Oncology, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q1 2025	55%	+1.2%	+2.1%	31 Mar 2025
Q4 2024	49%	-20%	-29%	31 Dec 2024
Q3 2024	49%	-26%	-35%	30 Sep 2024
Q2 2024	51%	-26%	-34%	30 Jun 2024
Q1 2024	54%	-5.6%	-9.4%	31 Mar 2024
Q4 2023	69%	+34%	+99%	31 Dec 2023
Q3 2023	75%	+56%	+298%	30 Sep 2023
Q2 2023	77%	+68%	+745%	30 Jun 2023
Q1 2023	60%	+54%	+965%	31 Mar 2023
Q4 2022	35%			31 Dec 2022
Q3 2022	19%			30 Sep 2022
Q2 2022	9.1%			30 Jun 2022
Q1 2022	5.6%			31 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.